WeightWatchers CEO Sima Sistani abruptly stepped down Friday after a two-year stint that included a controversial embrace of weight-loss drugs like Ozempic and Wegovy. Sistani pushed the 61-year ...
Sistani leaves the parent company of the once popular points-based weight loss program as it faces challenges in adapting to the growing popularity of weight loss drugs like Wegovy and Zepbound.
Sistani’s departure follows a turbulent two years, as she tried to steer the legacy weight-loss brand in new directions in the age of Ozempic and other GLP-1 drugs. That included an ...